We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Infectious Disease Consultation Lowers Risk of Bloodstream Infection Mortality

By LabMedica International staff writers
Posted on 29 Jan 2020
Among patients with common bloodstream infections, lack of infectious disease consultation was associated with a more than fourfold increased hazard of death at three months.

Bloodstream infections result in high morbidity and mortality. More...
Multiple studies have demonstrated that infectious diseases (ID) consultation is associated with improved outcomes, especially in Staphylococcus aureus bacteremia and candidemia.

Infectious disease specialists at the University of Minnesota Medical Center (Minneapolis, MN, USA) performed a retrospective cohort study of bloodstream infections at the referral center. They investigated the impact of ID consultation, which they noted is not mandatory at all facilities, on the mortality of patients hospitalized with Methicillin-resistant S. aureus (MRSA), Candida and Pseudomonas bloodstream infections. As part of the analysis, they recorded whether an ID consultation note was present in the electronic medical record, when patients received appropriate antibiotics and whether the hospitalization included an intensive care unit (ICU) stay.

The team identified 229 bloodstream infections between 2016 and 2018: 99 with MRSA, 69 with Candida and 61 with Pseudomonas. Of these, 181 had an ID consultation. Their analysis showed that patients without ID consultation had a 4.5 increased hazard of death at three months compared with those who received ID consultation. Among MRSA infections, mortality with ID consultation was 22% compared with 67% without, and the median time to death in those without an ID consultation was two days compared with 27 days in patients who received a consultation. Among patients with candidemia infection, the doctors found that without ID consultation, 63% died, compared with 32% of patients who received an ID consultation. The rate of mortality at three months was 63% among patients with Pseudomonas bacteremia infection who did not receive an ID consultation, compared with 32% who did.

Additionally, the team found that patients who received ID consultation were nine times more likely receive appropriate antibiotics or antifungals, six times more likely to have central lines removed and four times more likely to have echocardiography performed to evaluate patients for endocarditis. Supavit Chesdachai, MD, an internal medicine resident and first author of the study, said, “Bloodstream infections result in high morbidity and mortality. Multiple studies have demonstrated that infectious diseases consultation is associated with improved outcomes, especially in S. aureus bacteremia and candidemia.”

The investigators concluded that their study demonstrated that ID consultation is associated with significantly lower three-month mortality and lower inpatient mortality in persons with bloodstream infections. The benefit of ID consultation was found for MRSA, candidemia, and extended to Pseudomonas bacteremia. Automatic ID consultation may have the potential to improve patient survival; prospective evaluation of such an intervention is warranted. The study was published on January 11, 2020 in the journal Open Forum Infectious Diseases.

Related Links:
University of Minnesota Medical Center


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Gold Member
Aspiration System
VACUSAFE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Acute lymphoblastic leukemia in children and young people requires careful relapse risk assessment as treatment expands beyond standard chemotherapy. (Image Credit: Shutterstock)

New Risk-Stratification Tool Predicts Relapse After Blinatumomab in Childhood ALL

Acute lymphoblastic leukemia in children and young people requires careful assessment of relapse risk, particularly as treatment approaches move beyond standard chemotherapy. Traditional relapse predictors... Read more

Pathology

view channel
Image Credit: Adobe Stock

AI Pathology Approach Closely Aligns With Breast Cancer Genomic Risk Classification

In early-stage breast cancer, precision oncology relies on biological information to guide personalized treatment decisions. Because access to tissue-based genomic testing may be limited, there is growing... Read more

Technology

view channel
Image Credit: Adobe Stock

AI Models Use Routine Blood Tests and Health Records to Predict Cancer Risk

Cancer screening programs cover only certain cancers and often rely on broad eligibility criteria, limiting individualized risk assessment across multiple cancer types. Routine health data, including blood... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.